Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading ...

Among adults with COPD, the likelihood for having mucus plugs on CT can be determined using a tool that considers 11 “readily ...

Researchers may have found a new target in chronic obstructive pulmonary disease (COPD) symptoms that could potentially save more lives. The study focused on mucus plugs, which clog airways in the ...

Dupilumab reduces mucus plugging and improves lung function in patients with moderate-to-severe type 2 asthma.

HealthDay News — Dupilumab reduces mucus plug scores and improves lung function in patients with moderate-to-severe asthma and high baseline mucus plug scores, according to a study published online ...

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by cigarette smoking or long-term exposure to air pollutants. While there is ...

A retrospective analysis of patient data from the COPDGene study suggests that targeting mucus plugs could help prevent deaths from chronic obstructive pulmonary disease - the fourth leading cause of ...

A retrospective analysis of patient data from the COPDGene study suggests that targeting mucus plugs could help prevent deaths from chronic obstructive pulmonary disease—the fourth leading cause of ...

Patients with poorly controlled asthma and mucus plugs had significantly more airflow obstruction, type 2 inflammation and severe exacerbations, according to a study published in The Journal of ...

WASHINGTON -- Dupilumab (Dupixent) reduced airway inflammation and increased lung capacity in patients with uncontrolled, moderate-to-severe asthma, while also reducing troublesome mucus plugs, a ...

Researchers used a proprietary, validated scoring system to compare data from 146 adults with severe asthma against that of 22 healthy controls. Some 58% of patients with severe asthma, versus only ...